rxstat › Shortages › Verapamil
Verapamil shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Verapamil products are in shortage in Canada (8 of 20 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
In shortage since
Mar 19, 2014
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageMYLAN-VERAPAMIL SR
180MG · TABLET (EXTENDED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02450488 · since Sep 7, 2022, no end estimate · Disruption of the manufacture of the drug.
Active shortageMYLAN-VERAPAMIL SR
240MG · TABLET (EXTENDED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02450496 · since Sep 7, 2022, no end estimate · Disruption of the manufacture of the drug.
Active shortageISOPTIN SR
240MG · TABLET (EXTENDED-RELEASE) · BGP PHARMA ULC
DIN 00742554 · since Jan 24, 2020, no end estimate · Delay in shipping of the drug.
Active shortageISOPTIN SR
180MG · TABLET (EXTENDED-RELEASE) · BGP PHARMA ULC
DIN 01934317 · since Aug 10, 2020, no end estimate · Disruption of the manufacture of the drug.
Active shortageAPO-VERAP SR
240MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02246895 · since Mar 19, 2014, no end estimate · Disruption of the manufacture of the drug.
Active shortageAPO-VERAP SR
120MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02246893 · since Apr 17, 2015, no end estimate · Disruption of the manufacture of the drug.
Active shortageAPO-VERAP SR
180MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02246894 · since Apr 17, 2015, no end estimate · Disruption of the manufacture of the drug.
Active shortageRIVA-VERAPAMIL SR
240MG · TABLET (EXTENDED-RELEASE) · LABORATOIRE RIVA INC
DIN 02248082 · since Oct 20, 2016, no end estimate · Disruption of the manufacture of the drug.
ResolvedMYLAN-VERAPAMIL SR
120MG · TABLET (EXTENDED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02210347 · ended May 11, 2026 · Disruption of the manufacture of the drug.
ResolvedAA-VERAP
120MG · TABLET · AA PHARMA INC
DIN 00782491 · ended Mar 31, 2026 · Disruption of the manufacture of the drug.
ResolvedAA-VERAP
80MG · TABLET · AA PHARMA INC
DIN 00782483 · ended Mar 31, 2026 · Disruption of the manufacture of the drug.
ResolvedAPO-VERAP TABLET 120MG
120MG · TABLET · APOTEX INC
DIN 00782491 · ended Nov 14, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Verapamil is currently affected by 8 active shortage reports filed with Health Canada by MYLAN PHARMACEUTICALS ULC, BGP PHARMA ULC, APOTEX INC, LABORATOIRE RIVA INC.
The reported causes are: disruption of the manufacture of the drug; delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Verapamil is classified under “SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF” (ATC C08DA).
Recent changes
Common questions
When will Verapamil be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Verapamil in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.